Ryeqo
Active substance: relugolix, norethisterone acetate, estradiol hemihydrate
relugolix, norethisterone acetate, estradiol hemihydrate
Centralised EU authorisationActive
Marketing holder: Gedeon Richter Plc.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
- relugolix
- norethisterone acetate
- estradiol hemihydrate
Products containing relugolix in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| US 2 |
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-db41-7e55-99fe-83a0651e2f64;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005267
- Registration status
- Active
- ATC code
- H01CC54
Sources
- product · EMA · EMEA/H/C/005267 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005267 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005267 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/005267 · Verified 2026-10-09
- ingredients.2 · EMA · EMEA/H/C/005267 · Verified 2026-10-09